See also this year's filing and all EDGAR filings for this company.
PDF Report 0000748592_2026_Ernexa_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0000748592, Ernexa Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,133,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,044,000 |
| 2 | PropertyPlantAndEquipmentNet | 94,000 |
| 3 | remainder_Assets | 563,000 |
| 4 | LiabilitiesCurrent | 3,113,000 |
| 5 | LiabilitiesNoncurrent | 320,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 19,851 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,783,447 |
| 9 | ResearchAndDevelopmentExpense | 4,184,003 |
| 10 | remainder_Expenses | -549,569 |
| 11 | remainder_Revenues | -105,083 |
| 12 | remainder_NetIncome | -14,557,297 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,834,000 |
| 1 | Liabilities | 3,433,000 |
| 2 | Expenses | 9,437,732 |
| 3 | Revenues | -105,083 |
| 4 | StockholdersEquity | 2,401,000 |
| 5 | NetIncome | -24,100,112 |
| 6 | ComprehensiveNetIncome | -24,100,112 |
| 7 | BaseVar | 16,683,556 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.07 |
| 9 | EconomicCapitalRatio | 0.374 |